Trial Profile
Sofosbuvir + weight-based ribavirin in interferon-ineligible patients with chronic hepatitis C and advanced cirrhosis.
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 28 Aug 2015
Price :
$35
*
At a glance
- Drugs Ribavirin (Primary) ; Sofosbuvir (Primary)
- Indications Hepatitis C; Liver cirrhosis
- Focus Therapeutic Use
- 28 Aug 2015 New trial record